The Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities document updates the previous version published in 2002. This revision covers:
- major studies on bradyarrhythmias and tachyarrhythmias, which may be treated optimally with device therapy;
- changes in the management of heart failure that involve both drug and device therapy; and
- advances in the technology of devices to treat, delay, and even prevent morbidity and mortality from bradyarrhythmias, tachyarrhythmias, and heart failure.